Court overturns CMA’s excessive pricing drug fine

Charley Connor

07 June 2018

Court overturns CMA’s excessive pricing drug fine

MJ_Prototype/iStock

The UK’s Competition Appeal Tribunal has overturned a €101.5 million fine on Pfizer and Flynn Pharma for excessively pricing an epilepsy drug.